Alkermes plc (ALKS) has disclosed a new risk, in the Corporate Activity and Growth category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alkermes plc faces significant risks regarding its proposed acquisition of Avadel, which may not be completed within the anticipated timeline or at all. The acquisition is contingent upon several conditions, including shareholder approval, court sanction, and regulatory clearances, which may encounter delays or obstacles. Additionally, unforeseen costs, liabilities, or competing offers could further complicate the process. Any disruption or failure in completing the acquisition could adversely impact Alkermes’ business operations, financial condition, and market share value.
The average ALKS stock price target is $42.10, implying 35.81% upside potential.
To learn more about Alkermes plc’s risk factors, click here.